Benjamin F. Edwards & Company, Inc. Prime Medicine, Inc. Transaction History

Benjamin F. Edwards & Company, Inc.

  • $5.69 Billion
  • Q2 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 25,326 shares of PRME stock, worth $47,612. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,326
Previous 427 5831.15%
Holding current value
$47,612
Previous $3,000 4233.33%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$4.3 - $8.03 $107,065 - $199,938
24,899 Added 5831.15%
25,326 $130,000
Q1 2024

Apr 29, 2024
BUY
$6.35 - $9.39 $2,711 - $4,009
427 New
427 $3,000

Others Institutions Holding PRME

# of Institutions
136
Shares Held
61M
Call Options Held
42.6K
Put Options Held
173K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $180M
More about PRME
Track This Portfolio

Track Benjamin F. Edwards & Company, Inc. Portfolio

Follow Benjamin F. Edwards & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email